SANOCHEMIA has elected to focus on the development and manufacture of novel drugs and diagnostics in selected indication areas. These include indications such as neurodegeneration, pain and oncology, as well as diagnostics based on contrast media.
-
Recent Posts
- EU-Backed SHOP4CF Announces Open Call For 4th Industrial Revolution Startups
- Founder Institute introduces new cohort in Finland for early-stage food tech entrepreneurs
- Shwetak Patel to highlight new approaches to healthcare and mobile
- Founder Institute CEO Adeo Ressi to run webinar offering COVID-19 startup survival tips
